公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2011 | Outcomes of switch to atazanavir-containing combination antiretroviral therapy in HIV-1-infected patients with hyperlipidemia | Lu C.-L.; Lin Y.-H.; Wong W.-W.; Lin H.-H.; Ho M.-W.; Wang N.-C.; SZU-MIN HSIEH ; WANG-HUEI SHENG ; CHIEN-CHING HUNG ; Chen M.-Y. | Journal of Microbiology, Immunology and Infection | 14 | 10 | |
2021 | Real-World Experience with Coformulated Ledipasvir and Sofosbuvir for HIV-Positive Patients with HCV Genotype 2 Infection: A Multicenter, Retrospective Study | Liou B.-H.; HSIN-YUN SUN ; Yang C.-J.; Syue L.-S.; Lee Y.-L.; Tang H.-J.; Tsai H.-C.; Lin C.-Y.; Chen T.-C.; Lee C.-Y.; Huang S.-H.; Liu C.-W.; Lu P.-L.; Lin S.-P.; Wang N.-C.; ARISTINE CHENG ; Ko W.-C.; Cheng S.-H.; CHIEN-CHING HUNG ; the Taiwan HIV Study Group | Infectious Diseases and Therapy | 3 | 2 | |
2014 | Risk factors for healthcare-associated extensively drug-resistant Acinetobacter baumannii infections: A case-control study | Chan M.-C.; Chiu S.-K.; PO-REN HSUEH ; Wang N.-C.; Wang C.-C.; CHI-TAI FANG | PLoS ONE | 37 | 34 | |
2017 | Safety and immunogenicity of an inactivated cell culture-derived H7N9 influenza vaccine in healthy adults: A phase I/II, prospective, randomized, open-label trial | UN-IN WU ; SZU-MIN HSIEH ; Lee W.-S.; Wang N.-C.; HSIANG-CHI KUNG ; Ou T.-Y.; Chen F.-L.; Lin T.-Y.; YEE-CHUN CHEN ; SHAN-CHWEN CHANG | Vaccine | 24 | 23 | |
2021 | Screening for Cryptococcal Antigenemia and Burden of Cryptococcosis at the Time of HIV Diagnosis: A Retrospective Multicenter Study | Huang, Sung-Hsi; Lee, Chun-Yuan; Tsai, Chin-Shiang; Tsai, Mao-Song; Liu, Chun-Eng; Hsu, Wei-Ting; Chen, Hong-An; WANG-DA LIU ; Yang, Chia-Jui; HSIN-YUN SUN ; Ko, Wen-Chien; Lu, Po-Liang; Lee, Yuan-Ti; CHIEN-CHING HUNG ; YU-SHAN HUANG ; SUI-YUAN CHANG ; Taiwan HIV Study Group; Chen L.-Y.; Zhang J.-Y.; Chang H.-Y.; Liu W.-C.; Su Y.-C.; Wang N.-C.; Lin T.-Y.; KUAN-YIN LIN ; Yang C.-J.; Chen H.-A.; Tsai M.-S.; Lee Y.-C.; Cheng C.-Y.; Cheng S.-H.; YI-CHIA HUANG ; Huang S.-H.; Lee Y.-T.; Lin J.-J.; Lin S.-P.; Hsieh C.-Y.; Wang H.-W.; Ho M.-W.; Liu C.-E.; Lee Y.-L.; Chen G.-J.; Lin C.-Y.; Hung T.-C.; Tang H.-J.; Ku H.-C.; Li C.-W.; Tsai C.-S.; Lee N.-Y.; Ko W.-C.; Lu P.-L.; Lee C.-Y.; Chen Y.-H.; Lee C.-H.; Tsai H.-C.; Che T.-C.; Taiwan HIV Study Group | Infectious diseases and therapy | 1 | 1 | |
2017 | Trends and outcomes of late initiation of combination antiretroviral therapy driven by late presentation among HIV-positive Taiwanese patients in the era of treatment scale-up | KUAN-YIN LIN ; Cheng C.-Y.; Li C.-W.; Yang C.-J.; Tsai M.-S.; Liu C.-E.; Lee Y.-T.; Tang H.-J.; Wang N.-C.; Lin T.-Y.; Lee Y.-C.; Lin S.-P.; YU-SHAN HUANG ; Zhang J.-Y.; Ko W.-C.; Cheng S.-H.; CHIEN-CHING HUNG ; Taiwan HIV Study Group | PLoS ONE | 34 | 32 | |